Tags

Type your tag names separated by a space and hit enter

Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification.
J Dtsch Dermatol Ges 2014; 12(2):139-47JD

Abstract

BACKGROUND AND OBJECTIVES

In 2013 the first German S-3 guidelines on the diagnosis, treatment, and follow-up of melanoma were published in the framework of the German Guideline Program on Oncology. Quality indicators were developed at the same time as the guideline development process in order to implement the guideline recommendations.

PATIENTS AND METHODS

A multidisciplinary, interprofessional working group developed quality indicators following a standardized process.

RESULTS

Twelve quality indicators directly linked to guideline recommendations were generated and agreed on by consensus. They were integrated into the catalogue of requirements for dermato-oncological centers certified by the German Cancer Society.

CONCLUSIONS

The close cooperation between the guideline group and commission for certification allowed the guideline contents to be implemented in the form of quality indicators in everyday clinical practice. Adherence to the guidelines is required and continuously evaluated as part of certification.

Authors+Show Affiliations

German Cancer Society e.V, Germany.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

24238575

Citation

Follmann, Markus, et al. "Quality Assurance for Care of Melanoma Patients Based On Guideline-derived Quality Indicators and Certification." Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, vol. 12, no. 2, 2014, pp. 139-47.
Follmann M, Schadendorf D, Kochs C, et al. Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification. J Dtsch Dermatol Ges. 2014;12(2):139-47.
Follmann, M., Schadendorf, D., Kochs, C., Buchberger, B., Winter, A., & Wesselmann, S. (2014). Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification. Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 12(2), pp. 139-47. doi:10.1111/ddg.12238.
Follmann M, et al. Quality Assurance for Care of Melanoma Patients Based On Guideline-derived Quality Indicators and Certification. J Dtsch Dermatol Ges. 2014;12(2):139-47. PubMed PMID: 24238575.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification. AU - Follmann,Markus, AU - Schadendorf,Dirk, AU - Kochs,Corinna, AU - Buchberger,Barbara, AU - Winter,Anna, AU - Wesselmann,Simone, Y1 - 2013/11/14/ PY - 2013/07/01/received PY - 2013/09/19/accepted PY - 2013/11/19/entrez PY - 2013/11/19/pubmed PY - 2014/10/31/medline SP - 139 EP - 47 JF - Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG JO - J Dtsch Dermatol Ges VL - 12 IS - 2 N2 - BACKGROUND AND OBJECTIVES: In 2013 the first German S-3 guidelines on the diagnosis, treatment, and follow-up of melanoma were published in the framework of the German Guideline Program on Oncology. Quality indicators were developed at the same time as the guideline development process in order to implement the guideline recommendations. PATIENTS AND METHODS: A multidisciplinary, interprofessional working group developed quality indicators following a standardized process. RESULTS: Twelve quality indicators directly linked to guideline recommendations were generated and agreed on by consensus. They were integrated into the catalogue of requirements for dermato-oncological centers certified by the German Cancer Society. CONCLUSIONS: The close cooperation between the guideline group and commission for certification allowed the guideline contents to be implemented in the form of quality indicators in everyday clinical practice. Adherence to the guidelines is required and continuously evaluated as part of certification. SN - 1610-0387 UR - https://www.unboundmedicine.com/medline/citation/24238575/Quality_assurance_for_care_of_melanoma_patients_based_on_guideline_derived_quality_indicators_and_certification_ L2 - https://doi.org/10.1111/ddg.12238 DB - PRIME DP - Unbound Medicine ER -